All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel 
.
| Security |
Imputed
Share Price |
Prev
Shares |
Current
Shares |
Change
(Percent) |
Prev Value
(USD x1000) |
Current Value
(USD x1000) |
Change
(Percent) |
|---|
| BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| AXNX / Axonics, Inc.
|
|
|
|
|
|
|
|
| ASLN / ASLAN Pharmaceuticals Limited - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| LJPC / La Jolla Pharmaceutical Co.
|
|
|
|
|
|
|
|
| ALLK / Allakos Inc.
|
|
|
|
|
|
|
|
| EPIX / ESSA Pharma Inc.
|
|
|
|
|
|
|
|
| DMTK / DermTech, Inc.
|
|
|
|
|
|
|
|
| RXDX / Prometheus Biosciences Inc
|
|
|
|
|
|
|
|
| OM / Outset Medical, Inc.
|
|
|
|
|
|
|
|
| TELA / TELA Bio, Inc.
|
|
|
|
|
|
|
|
| UTRS / Minerva Surgical, Inc.
|
|
|
|
|
|
|
|
| OMIC / Singular Genomics Systems, Inc.
|
|
|
|
|
|
|
|
| SUMMIT HEALTHCRE ACQUISTN CO
/ UNIT 06/03/2026 (G8566R128) |
|
|
|
|
|
|
|
| / Third Harmonic Bio, Inc.
|
|
|
|
|
|
|
|
| ISO / IsoPlexis Corp
|
|
|
|
|
|
|
|
| GTH / Genetron Holdings Limited - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| CINC / CinCor Pharma Inc
|
|
|
|
|
|
|
|
| GLUE / Monte Rosa Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ARYE / ARYA Sciences Acquisition Corp V - Class A
|
|
|
|
|
|
|
|
| MSAC / Medicus Sciences Acquisition Corp - Class A
|
|
|
|
|
|
|
|
| / Nautilus Biotechnology Inc
|
|
|
|
|
|
|
|
| KYG5960S1241 / Medicus Sciences Acquisition Corp.
|
|
|
|
|
|
|
|
| / VENTYX BIOSCIENCES INC
|
|
|
|
|
|
|
|
| TSVT / 2seventy bio, Inc.
|
|
|
|
|
|
|
|
| RACB / Research Alliance Corp II - Class A
|
|
|
|
|
|
|
|
| FVAM / 5:01 Acquisition Corp.
|
|
|
|
|
|
|
|
| ARGX / argenx SE - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| CCCC / C4 Therapeutics, Inc.
|
|
|
|
|
|
|
|
| TNDM / Tandem Diabetes Care, Inc.
|
|
|
|
|
|
|
|
| PRCT / PROCEPT BioRobotics Corporation
|
|
|
|
|
|
|
|
| MXCT / MaxCyte, Inc.
|
|
|
|
|
|
|
|
| / Cytek Biosciences, Inc.
|
|
|
|
|
|
|
|
| DNAY / Codex DNA Inc
|
|
|
|
|
|
|
|
| SLGC / Standard BioTools Inc.
|
|
|
|
|
|
|
|
| LUNG / Pulmonx Corporation
|
|
|
|
|
|
|
|
| MIST / Milestone Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
| PEN / Penumbra, Inc.
|
|
|
|
|
|
|
|
| RARE / Ultragenyx Pharmaceutical Inc.
|
|
|
|
|
|
|
|
| MASI / Masimo Corporation
|
|
|
|
|
|
|
|
| XGN / Exagen Inc.
|
|
|
|
|
|
|
|
| CDXS / Codexis, Inc.
|
|
|
|
|
|
|
|
| GH / Guardant Health, Inc.
|
|
|
|
|
|
|
|
| AADI / Aadi Bioscience, Inc.
|
|
|
|
|
|
|
|
| PMVP / PMV Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| APYX / Apyx Medical Corporation
|
|
|
|
|
|
|
|
| URGN / UroGen Pharma Ltd.
|
|
|
|
|
|
|
|
| RCEL / AVITA Medical, Inc.
|
|
|
|
|
|
|
|
| RXST / RxSight, Inc.
|
|
|
|
|
|
|
|
| ILMN / Illumina, Inc.
|
|
|
|
|
|
|
|
| AGEN / Agenus Inc.
|
|
|
|
|
|
|
|
| PNT / POINT Biopharma Global Inc.
|
|
|
|
|
|
|
|
| LSAQ / LifeSci Acquisition II Corp
|
|
|
|
|
|
|
|
| AXSM / Axsome Therapeutics, Inc.
|
|
|
|
|
|
|
|
| MRTX / Mirati Therapeutics, Inc.
|
|
|
|
|
|
|
|
| MGNX / MacroGenics, Inc.
|
|
|
|
|
|
|
|
| VERU / Veru Inc.
|
|
|
|
|
|
|
|
| MASS / 908 Devices Inc.
|
|
|
|
|
|
|
|
| CHAQ / Chardan Healthcare Acquisition 2 Corp
|
|
|
|
|
|
|
|
| BLSA / BCLS Acquisition Corp - Class A
|
|
|
|
|
|
|
|
| RCOR.WS / Renovacor, Inc. Warrants, enti Warrants, entitling the holder thereof to purchase one-half (1/2) of a share of common stock at a price of $11.50 per whole share
|
|
|
|
|
|
|
|
| CYTK / Cytokinetics, Incorporated
|
|
|
|
|
|
|
|
| AKYA / Akoya Biosciences, Inc.
|
|
|
|
|
|
|
|
| OLK / Olink Holding AB (publ) - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| CYRX / Cryoport, Inc.
|
|
|
|
|
|
|
|
| ACET / Adicet Bio, Inc.
|
|
|
|
|
|
|
|
| APEN / Apollo Endosurgery Inc
|
|
|
|
|
|
|
|
| NYXH / Nyxoah SA
|
|
|
|
|
|
|
|
| STOK / Stoke Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ALGN / Align Technology, Inc.
|
|
|
|
|
|
|
|
| QTRX / Quanterix Corporation
|
|
|
|
|
|
|
|
| RGNX / REGENXBIO Inc.
|
|
|
|
|
|
|
|
| ISEE / IVERIC bio Inc
|
|
|
|
|
|
|
|
| TWST / Twist Bioscience Corporation
|
|
|
|
|
|
|
|
| MIRO / Miromatrix Medical Inc
|
|
|
|
|
|
|
|
| JNCE / Jounce Therapeutics Inc
|
|
|
|
|
|
|
|
| TNYA / Tenaya Therapeutics, Inc.
|
|
|
|
|
|
|
|
| BWAY / BrainsWay Ltd. - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| CTIC / CTI BioPharma Corp
|
|
|
|
|
|
|
|
| CTMX / CytomX Therapeutics, Inc.
|
|
|
|
|
|
|
|
| JNJ / Johnson & Johnson
|
|
|
|
|
|
|
|
| OYST / Oyster Point Pharma Inc
|
|
|
|
|
|
|
|
| PYXS / Pyxis Oncology, Inc.
|
|
|
|
|
|
|
|
| HSAQ / Health Sciences Acquisitions Corp 2
|
|
|
|
|
|
|
|
| CSTL / Castle Biosciences, Inc.
|
|
|
|
|
|
|
|
| SGHT / Sight Sciences, Inc.
|
|
|
|
|
|
|
|
| CLDX / Celldex Therapeutics, Inc.
|
|
|
|
|
|
|
|
| LABP / Landos Biopharma, Inc.
|
|
|
|
|
|
|
|
| VCEL / Vericel Corporation
|
|
|
|
|
|
|
|
| CUTRQ / Cutera, Inc.
|
|
|
|
|
|
|
|
| GMED / Globus Medical, Inc.
|
|
|
|
|
|
|
|
| ARYD / ARYA Sciences Acquisition Corp IV
|
|
|
|
|
|
|
|
| ROIV / Roivant Sciences Ltd.
|
|
|
|
|
|
|
|
| TMO / Thermo Fisher Scientific Inc.
|
|
|
|
|
|
|
|
| AVDL / Avadel Pharmaceuticals plc
|
|
|
|
|
|
|
|
| FULC / Fulcrum Therapeutics, Inc.
|
|
|
|
|
|
|
|
| TXG / 10x Genomics, Inc.
|
|
|
|
|
|
|
|
| ESTA / Establishment Labs Holdings Inc.
|
|
|
|
|
|
|
|
| PTGX / Protagonist Therapeutics, Inc.
|
|
|
|
|
|
|
|
| IMTX / Immatics N.V.
|
|
|
|
|
|
|
|
| NTRA / Natera, Inc.
|
|
|
|
|
|
|
|
| MLTX / MoonLake Immunotherapeutics
|
|
|
|
|
|
|
|
| IMUX / Immunic, Inc.
|
|
|
|
|
|
|
|
| ALNY / Alnylam Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| PTCT / PTC Therapeutics, Inc.
|
|
|
|
|
|
|
|
| RLMD / Relmada Therapeutics, Inc.
|
|
|
|
|
|
|
|
| RCKT / Rocket Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| RNA / Avidity Biosciences, Inc.
|
|
|
|
|
|
|
|
| TARS / Tarsus Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| GHRS / GH Research PLC
|
|
|
|
|
|
|
|
| ACAD / ACADIA Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
| IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
